NHSA opens up £45bn Commonwealth life sciences economies to the North of England

Memorandum of Understanding opens door to increased trading between companies in North of England and Canadian and Australian markets

Pictured is NHSA chief executive, Dr Yadi; with Premier of Queensland, Annastacia Palaszczuk and Maro Pennisi of Life Sciences Queensland

The Northern Health Science Alliance (NHSA) has signed memorandum of understandings (MOUs) with Life Sciences Queensland (LSQ) in Australia and SCAN Health and World Health Innovation (WIN) in Canada to open the door to working across the Commonwealth countries.

These joint working arrangements will benefit UK, Canadian and Australian patients and industry by helping new expertise and research to be shared quickly and effectively across the countries’ booming life sciences economies.

We want to best and brightest companies to come and work in the North of England – and for the best and brightest of our companies to spread their wings internationally

The North of England is a world-leader in health science with £10.8bn added to the UK’s economy each year from the sector.

These MOUs will open up opportunities for UK companies to expand into Australia, which has a £28bn life sciences economy; and Canada, which has a £17bn life sciences economy; and for their companies to bring the latest health technology and treatment to the North.

Dr Hakim Yadi, chief executive of the Northern Health Science Alliance, said: “This joint working arrangement means that the life sciences industries in Australia, Canada and the UK will benefit from closer relationships.

“There is a real international appetite to work with the North’s health research system – demonstrated by these MOU signings and our recent MoU signing with the leading Singaporean MedTech Accelerator, Zicom MedTac Pte. As a result there are now a number of Singaporean companies conducting research studies in partnership with Northern universities and hospitals.

“We want to best and brightest companies to come and work in the North of England – and for the best and brightest of our companies to spread their wings internationally.

Dr Yadi with Dr Anne Snowdon of SCAN Health

“Ultimately, these exchange between NHSA and Canada and Australian life sciences organisations will benefit patients in the healthcare system globally.”

Mario Pennisi, chief executive of Life Sciences Queensland, added: “The UK presents a significant market opportunity for our members and this alliance with NHSA provides the perfect entry point to facilitate this.

By working together with our combined members and partners around the world we believe we can advance knowledge and impact of supply chain maturity in health systems

“Working with our British colleagues provides us an excellent opportunity to leverage a revitalised interest in the Commonwealth.”

And Dr Anne Snowdon, scientific director and chief executive of SCAN Health and chairman of WIN, said: “Partnering with NHSA gives us tremendous reach and engagement opportunities with Northern UK healthcare systems and their respective research networks to advance health system innovation and broker global health sector collaboration that facilitates knowledge exchange to improve performance, safety and health outcomes.

“By working together with our combined members and partners around the world we believe we can advance knowledge and impact of supply chain maturity in health systems."

The NHSA is a partnership established by the leading universities, NHS teaching hospital trusts, and Academic Health Science Networks in the North of England.

Companies